Sulfite allergy occurs when your immune system is overly sensitive to sulfite. It can cause symptoms like itching, swelling, ...
A new study from Karolinska Institutet suggests that some widely used heartburn medications may be linked to kidney problems ...
Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat and cardiovascular risks in MASLD models. The drug duo works better together ...
Using two types of cardiovascular drugs together could help to treat fatty liver disease and reduce the number of severe cases. This is the finding of researchers from the University of Barcelona (UB) ...
Each body is unique—particularly your gut; everything from what you eat to your genetics can influence its exact makeup. Now, new research suggests that medications you took years ago may have an ...
A well-established diabetes drug alleviated brain inflammation in a female mouse model of multiple sclerosis, suggesting the long-used medicine could be repurposed to combat MS in people with female ...
Australian researchers tested drugs at intestinal concentrations similar to those found in humans, making the results highly relevant to real-world clinical use.
Researchers have revealed a surprising new side effect linked to GLP-1 agonists, such as Ozempic, Wegovy, Mounjaro and Zepbound. These popular treatments for diabetes and obesity could interfere with ...
Metabolic dysfunction-associated steatotic liver disease is the most common liver disease in the world, affecting about one-third of the adult population. This disorder is characterized by the ...
A new “unusual” side effect of weight-loss drugs is becoming more common, research has suggested. Weight-loss drugs such as Ozempic and Wegovy have soared in popularity. About one in eight U.S. adults ...
A new experimental therapy helps restore the heart’s flexibility in models of stiffened heart failure. Michael Gotthardt and his colleagues at the Max Delbrück Center are working with U.S. researchers ...
From sagging jowls and sulfurous burps to deflated breasts and surprise pregnancies, the side effects of GLP-1 weight-loss drugs have ranged from subtle to strange. Now, new research suggests that ...